Table 2. Clinical and Paraclinical Characteristics of the Participants Receiving Second Generation (LD) or Third Generation (Marolin) COCs Before Intervention.
| Characteristics | LD® Mean (SD)a | Marolin® Mean (SD)a | Statistical Indicators |
|---|---|---|---|
| BMI, kg/m 2 | 28.5 (2.9) | 28.7 (2.78) | Tb = -0.4, df = 135, P = 0.638 |
| Systolic BP, mmHg | 100 (95 to 105)c | 100 (100 to 105)c | Zd = -1.31, P = 0.190 |
| Dystolic BP, mmHg | 60 (60 to 70)c | 65 (60 to70)c | Zd = -85, P = 0.393 |
| HDL-C, mg/dL | 47.9 (10.71) | 45.78 (9.83) | Tb= 1.2, df = 135, P=0.230 |
| LDL-C, mg/dL | 93.69 (28.25) | 99.93 (29.06) | Tb = -1.27, df = 135, P = 0.205 |
| TC, mg/dL | 158.55 (28.99) | 164.88 (31.32) | Tb = -1.22, df = 135, P = 0.222 |
| TG, mg/dL | 84.33 (37.17) | 95.5 (39.29) | Tb = -1.70, df = 135, P = 0.090 |
| FPG, mg/dL | 78.37 (9.87) | 80.38 (10.51) | Tb = -1.15, df = 135, P = 0.252 |
| 2-hour 75-g OGTT, mg/dL | 91.62 (16.15) | 85.69 (19.59) | Tb = 1.93, df = 135, P = 0.055 |
aMean (Standard Deviation)
bT-test
cMedian (P25 to P75)
dMann-Whitney U test